v3.23.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 5,836,684 $ 8,434,554
Short-term investments 12,726,545 35,837,309
Accounts receivable 260,191 81,456
Grant receivable   1,524,522
Income tax refund receivable 600,877 600,877
Prepaid expenses and other current assets 3,357,644 3,575,541
Total Current Assets 22,781,941 50,054,259
Property and Equipment, net 19,110,942 20,480,375
Intangible assets, net 7,941,875 8,669,375
Goodwill 3,873,079 3,301,959
Operating lease right-of-use asset 5,471,414 6,005,147
Finance lease right-of-use asset 19,312,783 15,329,075
Other assets 1,456,039 260,011
Deposits 236,334 296,711
Total Assets 80,184,407 104,396,912
Current Liabilities    
Accounts payable 2,322,048 4,424,053
Deferred revenue, current portion 2,702,024 1,585,808
Operating lease liability, current portion 343,047 490,378
Finance lease liability, current portion 260,488 301,048
Accrued expenses and other liabilities 3,479,325 4,301,922
Contingent consideration, current portion 6,234,115 6,934,114
Total Current Liabilities 15,341,047 18,037,323
Long Term Liabilities    
Deferred revenue, net of current portion 32,500 32,500
Operating lease liability, net of current portion 2,912,038 3,079,887
Financing lease liability, net of current portion 7,728,522 5,520,034
Contingent consideration, net of current portion 6,100,000 5,290,500
Other liabilities 1,002,904  
Total Liabilities 33,117,011 31,960,244
Commitments and Contingencies (Note 13 and Note 14)
Stockholders' Equity    
Common stock, $0.0002 par value; 250,000,000 shares authorized, 26,047,164 and 25,661,488 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 5,210 5,126
Additional paid-in capital 284,453,899 283,019,456
Accumulated deficit (235,830,321) (209,153,659)
Accumulated other comprehensive income 104,962 51,924
Total Stockholders' Equity - NightHawk Biosciences, Inc. 48,733,750 73,922,847
Non-Controlling Interest (1,666,354) (1,486,179)
Total Stockholders' Equity 47,067,396 72,436,668
Total Liabilities and Stockholders' Equity $ 80,184,407 $ 104,396,912

Source

PDF HTML 10-Q Filing
ZIP XLS XBRL